DOJ said two companies tried to drive certain beneficiaries away because their disabilities could make coverage costly.
Kickbacks
At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
We discussed improper marketing strategies, upcoding and billing issues, defense strategies for fraud cases with Tama Kudman and Barry Posner.
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
Pilot program at DOJ will give immunity to executives providing information about corporate misconduct in which they were involved.
Millions of dollars in bribes were paid to Ecuadorian government officials.